COVID-19 mRNA Vaccine and Myocarditis
Coronavirus disease 2019 (COVID-19) is believed to have originated in the Hua nan South China Seafood Market in Wuhan and can present with a spectrum of clinical manifestations. We report the case of 24-year-old male patient who developed chest pain after administration of the second dose of the Pfi...
Main Authors: | Balraj Singh, Parminder Kaur, Leon Cedeno, Taulant Brahimi, Prem Patel, Hartaj Virk, Fayez Shamoon, Manesh Bikkina |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2021-06-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/2681 |
Similar Items
-
Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
by: Bibhuti B. Das, et al.
Published: (2021-07-01) -
Myocarditis and pericarditis in patients with COVID-19
by: Jassim Zaheen Shah, et al.
Published: (2020-01-01) -
Myocarditis and pericarditis after vaccination for COVID‐19
by: Blake Hudson, et al.
Published: (2021-08-01) -
Post-mRNA COVID-19 Vaccination Myocarditis
by: Abhishek Matta, et al.
Published: (2021-08-01) -
The incidence of myopericarditis in patients with COVID-19
by: Atoosa Mostafavi, et al.
Published: (2021-08-01)